Target intelligence / Profile preview

Thallium ion chelator (None)

Target
None
Molecular classification
Chelating agent, synthetic ligand
01

Overview

A thallium ion chelator is a synthetic or natural ligand designed to tightly and selectively bind thallium ions (Tl⁺ or Tl³⁺). These molecules utilize donor atoms—often nitrogen and oxygen in specific geometric arrangements—to form stable coordination complexes that sequester thallium, reducing its toxic potential or facilitating its use in radiolabeling (such as Thallium-201 for nuclear imaging)[1][3][4][5]. Numerous chemical scaffolds have been explored, including cryptands such as Kryptofix-222, tropolone derivatives like tropolonate and hinokitiolate, and polyaminopolycarboxylic acids like pypa. Chelators are evaluated for their binding strength, selectivity, and ability to function under physiological conditions. They are not biological macromolecules, receptors, enzymes, or transporters but play a critical role in toxicology, radiochemistry, and diagnostic medicine[1][3][4][5].

Other names
Thallium chelating agentThallium chelatorThallium sequestrantKryptofix-222Tropolonatepypa
02

Mechanism of action

Chemical chelation: Formation of stable complexes with thallium ions through coordination of electron-donor atoms (N, O), effectively trapping and neutralizing the metal ion to facilitate excretion or allow safe use in diagnostic nuclear medicine

03

Biological functions

Metal ion sequestrationHeavy metal detoxificationRadiometal complex stabilization (for imaging applications)
04

Disease associations

Used for treating or diagnosing thallium poisoningIn nuclear medicine for radiolabeling purposes
05

Safety considerations

Chelator selectivity may be incomplete, risking binding of essential metal ions (Ca²⁺, Zn²⁺, etc.)Potential toxicity or side effects of chelator molecules if not properly metabolized or excretedFailure to fully chelate thallium may leave residual toxicity
06

Interacting drugs

Kryptofix-222

4 more in the full profile.

07

Biomarkers

None (Chelator efficacy can be monitored by measuring thallium levels in blood/urine, but not via classical molecular biomarkers)

Beyond the preview

Go deeper on Thallium ion chelator (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thallium ion chelator (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call